These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 34710063)

  • 1. The intersection of COVID-19 and autoimmunity.
    Knight JS; Caricchio R; Casanova JL; Combes AJ; Diamond B; Fox SE; Hanauer DA; James JA; Kanthi Y; Ladd V; Mehta P; Ring AM; Sanz I; Selmi C; Tracy RP; Utz PJ; Wagner CA; Wang JY; McCune WJ
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34710063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.
    Opdenakker G; Van Damme J
    Cytokine Growth Factor Rev; 2021 Apr; 58():134-140. PubMed ID: 33563543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals.
    Cañas CA
    Med Hypotheses; 2020 Dec; 145():110345. PubMed ID: 33080459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
    Baiocchi GC; Vojdani A; Rosenberg AZ; Vojdani E; Halpert G; Ostrinski Y; Zyskind I; Filgueiras IS; Schimke LF; Marques AHC; Giil LM; Lavi YB; Silverberg JI; Zimmerman J; Hill DA; Thornton A; Kim M; De Vito R; Fonseca DLM; Plaça DR; Freire PP; Camara NOS; Calich VLG; Scheibenbogen C; Heidecke H; Lattin MT; Ochs HD; Riemekasten G; Amital H; Shoenfeld Y; Cabral-Marques O
    J Med Virol; 2023 Feb; 95(2):e28538. PubMed ID: 36722456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis.
    Taghadosi M; Safarzadeh E; Asgarzadeh A; Roghani SA; Shamsi A; Jalili C; Assar S; Soufivand P; Pournazari M; Feizollahi P; Nicknam MH; Asghariazar V; Vaziri S; Shahriari H; Mohammadi A
    Rev Med Virol; 2023 Mar; 33(2):e2412. PubMed ID: 36471421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SARS-CoV-2 infection and autoimmunity].
    Meyer-Bahlburg A
    Z Rheumatol; 2024 Feb; 83(1):34-40. PubMed ID: 38108865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
    Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
    Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection.
    Chen C; Amelia A; Ashdown GW; Mueller I; Coussens AK; Eriksson EM
    Mol Med; 2021 Dec; 27(1):160. PubMed ID: 34930107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
    Fatone MC
    Curr Rheumatol Rev; 2021; 17(1):7-16. PubMed ID: 33019935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells.
    Castleman MJ; Stumpf MM; Therrien NR; Smith MJ; Lesteberg KE; Palmer BE; Maloney JP; Janssen WJ; Mould KJ; Beckham JD; Pelanda R; Torres RM
    Front Immunol; 2022; 13():988125. PubMed ID: 36131937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC.
    Visvabharathy L; Dalil N; Leonor L; Zhu C; Orban ZS; Jimenez M; Lim PH; Penaloza-MacMaster P; Koralnik IJ
    Immunohorizons; 2024 Aug; 8(8):577-585. PubMed ID: 39186606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19.
    Woodruff MC; Ramonell RP; Haddad NS; Anam FA; Rudolph ME; Walker TA; Truong AD; Dixit AN; Han JE; Cabrera-Mora M; Runnstrom MC; Bugrovsky R; Hom J; Connolly EC; Albizua I; Javia V; Cashman KS; Nguyen DC; Kyu S; Singh Saini A; Piazza M; Tipton CM; Khosroshahi A; Gibson G; Martin GS; Maier CL; Esper A; Jenks SA; Lee FE; Sanz I
    Nature; 2022 Nov; 611(7934):139-147. PubMed ID: 36044993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.
    Oakes EG; Dillon E; Buhler KA; Guan H; Paudel M; Marks K; Adejoorin I; Yee J; Ellrodt J; Tedeschi S; Sparks J; Case SM; Hsu T; Solomon DH; Jonsson AH; Alexander RV; Rao DA; Choi MY; Costenbader KH
    J Autoimmun; 2024 Sep; 148():103299. PubMed ID: 39096716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.